Results 1 to 10 of about 28,588 (290)
Demographics, Usage Patterns, and Safety of Male Users of Clomiphene in the United States [PDF]
The World Journal of Men's Health, 2019 Purpose The aim of this study was to characterize the demographics, usage patterns and complication rates of clomiphene use in male patients. Materials and Methods We retrospectively analyzed male patients from ages 20 to 55 years old who were prescribed
David Guo +4 more
semanticscholar +3 more sources
Frontiers in Endocrinology, 2023 Objective Using Mesh Meta Analysis to evaluate the efficacy of Acupuncture & Moxibustion, Clomiphene, Acupuncture & Moxibustion combined with Clomiphene for treating Polycystic Ovary Syndrome (PCOS), in order to provide evidence-based medical evidence ...
Lijie Yang +8 more
semanticscholar +3 more sources
The Effectiveness of Clomiphene Citrate and Letrozole for Ovulation Induction Related to Endometrial Thickness and Number of Dominant Follicle [PDF]
, 2016 The aim of the study is to know the effectiveness of clomiphene citrate and letrozole for ovulationrelated to endometrial thickness and number of dominant follicle. Study design was cross sectional basedon medical records of women who underwent ovulation
Madjid, V. (Veinardi) +3 more
core +3 more sources
Clomiphene Citrate for Male Hypogonadism and Infertility: An Updated Review [PDF]
, 2020 Clomiphene citrate (CC) is a selective estrogen receptor modulator, originally developed in 1956 and introduced into clinical medicine in 1967 for the treatment of female infertility.
Bryan Herzog +3 more
openalex +2 more sources
Pakistan Journal of Medical Sciences, 2020 Objective: This study was aimed to compare the clinical outcomes of ovulation induction (OI) by timed intercourse with letrozole (LTZ) and clomiphene citrate (CC). Methods: Three hundred and twenty-three patients with polycystic ovary syndrome (PCOS) who
Mehmet Nafi Sakar +1 more
openalex +2 more sources
Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome [PDF]
Human Reproduction, 2017 STUDY QUESTION: Would letrozole as a primary ovulation induction agent generate better pregnancy rates than clomiphene citrate (CC) in subfertile women with anovulatory polycystic ovarian syndrome (PCOS)? SUMMARY ANSWER: Participants receiving letrozole
Amer, Saad A. +4 more
core +3 more sources
Letrozole versus Clomiphene for Infertility in the Polycystic Ovary Syndrome [PDF]
New England Journal of Medicine, 2014 BACKGROUND Clomiphene is the current first-line infertility treatment in women with the polycystic ovary syndrome, but aromatase inhibitors, including letrozole, might result in better pregnancy outcomes. Full Text of Background...
Alvero, Ruben +22 more
core +3 more sources
Safety of clomiphene citrate: a literature review [PDF]
Cytotechnology (Dordrecht), 2017 Serkan Yılmaz +4 more
openalex +2 more sources
Clomiphene citrate for male infertility: A systematic review and meta‐analysis
Andrology, 2023 Male infertility is a prevalent and worldwide problem with various difficulties in treatment. Clomiphene citrate is a selective estrogen receptor modulator and may improve semen quality by stimulating hormone synthesis and spermatogenesis.
M. Huijben +5 more
semanticscholar +1 more source
Cureus, 2022 Demographic data regarding male infertility suggest an increase in prevalence. This is an entity with multifactorial etiology, hormonal causes are often encountered. Although treatment with clomiphene was advocated to stimulate gametogenesis, it is still
D. Puia, C. Pricop
semanticscholar +1 more source